- Home
- PHI vs CORT Comparison
PHI vs CORT Comparison
Compare PHI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHI
- CORT
- Stock Information
- Founded
- PHI 1928
- CORT 1998
- Country
- PHI Philippines
- CORT United States
- Employees
- PHI N/A
- CORT N/A
- Industry
- PHI Telecommunications Equipment
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- PHI Telecommunications
- CORT Health Care
- Exchange
- PHI Nasdaq
- CORT Nasdaq
- Market Cap
- PHI 4.8B
- CORT 5.6B
- IPO Year
- PHI 1953
- CORT N/A
- Fundamental
- Price
- PHI $22.38
- CORT $55.31
- Analyst Decision
- PHI
- CORT Strong Buy
- Analyst Count
- PHI 0
- CORT 4
- Target Price
- PHI N/A
- CORT $75.25
- AVG Volume (30 Days)
- PHI 78.9K
- CORT 791.4K
- Earning Date
- PHI 11-12-2024
- CORT 02-13-2025
- Dividend Yield
- PHI 7.55%
- CORT N/A
- EPS Growth
- PHI 147.52
- CORT 57.97
- EPS
- PHI 2.21
- CORT 1.26
- Revenue
- PHI $3,846,163,485.00
- CORT $628,555,000.00
- Revenue This Year
- PHI $4.78
- CORT $46.29
- Revenue Next Year
- PHI $4.33
- CORT $17.09
- P/E Ratio
- PHI $10.03
- CORT $43.87
- Revenue Growth
- PHI 3.33
- CORT 39.67
- 52 Week Low
- PHI $21.00
- CORT $20.84
- 52 Week High
- PHI $30.39
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- PHI 48.85
- CORT 58.22
- Support Level
- PHI $21.73
- CORT $49.00
- Resistance Level
- PHI $23.05
- CORT $52.17
- Average True Range (ATR)
- PHI 0.45
- CORT 1.76
- MACD
- PHI 0.08
- CORT 0.52
- Stochastic Oscillator
- PHI 48.51
- CORT 99.21
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line, and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.